Following the announcements in April and May 2022 of the intended sale of DSM's two remaining Materials businesses, these are now reported as assets held for sale and as Discontinued Operations. Going forward, DSM will only provide an outlook for its Continuing Operations (Health, Nutrition & Bioscience, and Corporate Activities). The outlook for these continuing activities is unchanged: DSM expects to deliver a high-single digit Adjusted EBITDA increase.

Royal DSM, a global purpose-led science-based company, announces that it pledges to purchase all of its electricity worldwide from renewable sources as well as further reduce greenhouse gas (GHG) emissions from its own operations faster with stringent new 2030 sustainability targets.

Symrise AG continues its growth course in the first half of 2022. The company saw a strong increase in sales and profit. Organic sales growth came to 10.2 %. Taking portfolio and exchange rate effects into account, sales in the reporting currency increased by 18.5 % to € 2,260 million (H1 2021: € 1,908 million).

Kensing, LLC (“Kensing” or the “Company”), a leading manufacturer of natural vitamin E, plant sterols, specialty esters and high-purity anionic surfactants, and a portfolio company of One Rock Capital Partners, LLC (“One Rock”), today announced that it has entered into a definitive agreement to acquire the Hopewell, Virginia amphoteric surfactants and specialty esters manufacturing operations (the “Business”) from Evonik Corporation (“Evonik”). 

Page 9 of 116

Back to top

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.